Ep. 60 - Public opinions on Wegovy and other weight loss drugs
MP3•Episodio en casa
Manage episode 375124383 series 3502474
Contenido proporcionado por Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights
…
continue reading
- COVID still matters, especially for those at risk
- The cost of weight loss drugs in the US compared to other countries
- The need for a free market economy in healthcare
- Public opinion on prescription weight loss drugs
- The potential impact of covering weight loss drugs under insurance
- COVID can still be severe for at-risk populations
- Vaccines can help prevent severe symptoms
- The US pays more for weight loss drugs compared to other countries
- The prevalence of obesity is high in the US
- The cost of covering weight loss drugs for all Americans would be significant
- Stay informed about the ongoing impact of COVID
- Consider the cost of weight loss drugs and explore alternative options
- Share your opinion on prescription weight loss drugs
- Advocate for healthcare policies that promote a free market economy
109 episodios